GSK

Ultime notizie

Titoli nella lingua originale della fonte.

• GSK | 10/2/26 (si apre in una nuova scheda)

  ktnv.com · 2 ott 2026

• Voting rights update pressures GSK stock near GBX1,847 resistance (si apre in una nuova scheda)

  Traders Union · 2 ott 2026

• The Technical Signals Behind (GSK) That Institutions Follow (si apre in una nuova scheda)

  Stock Traders Daily · 1 ott 2026

• Kristian Jensen: Begining a New Chapter at GSK After Novartis Journey (si apre in una nuova scheda)

  Oncodaily · 1 ott 2026

• GSK (GSK) reports 4.05B voting rights, with 271M shares held in treasury (si apre in una nuova scheda)

  Stock Titan · 1 ott 2026

• GSK adds liver candidate from Wave RNA partnership (si apre in una nuova scheda)

  European Biotechnology Magazine · 1 ott 2026

• What's behind GSK's latest 1.8% stock pullback? (si apre in una nuova scheda)

  Traders Union · 1 ott 2026

• GSK Updates Market on Total Voting Rights and Share Capital (si apre in una nuova scheda)

  TipRanks · 1 ott 2026

• 
  Abbott Stock And Other Healthcare Dividend Names Built For Supply Chain Shocks (si apre in una nuova scheda)

  Simply Wall St. · 1 ott 2026

• GSK plc : JP Morgan reiterates its Sell rating (si apre in una nuova scheda)

  marketscreener.com · 1 ott 2026

• Tyler Reynolds Joins GSK as Director, Digital Medicine (si apre in una nuova scheda)

  BioBuzz · 1 ott 2026

• Why Did Haleon (LSE:HLN) Draw Attention As GSK Completed Its Exit This Week? (si apre in una nuova scheda)

  kalkinemedia.com · 1 ott 2026

• How Is GSK (LSE:GSK) Stock Reacting This Week To Its Wave Life Sciences Liver Candidate? (si apre in una nuova scheda)

  kalkinemedia.com · 1 ott 2026

• Wave lands USD 12m as GSK advances SpiNA siRNA program (si apre in una nuova scheda)

  AllSci · 1 ott 2026

• Why is GSK stock down today? Selloff intensifies, key levels to watch (si apre in una nuova scheda)

  Traders Union · 1 ott 2026

• GSK (LSE:GSK) Expands TB Research as Gates Funding Continues (si apre in una nuova scheda)

  kalkinemedia.com · 1 ott 2026

• GSK Pharma stock enters a results blackout before Q2 FY27 (si apre in una nuova scheda)

  ad-hoc-news.de · 1 ott 2026

• Wave Life announces GSK’s selection of siRNA program to transition to GSK (si apre in una nuova scheda)

  TipRanks · 1 ott 2026

• GSK (LSE:GSK) Gets Extended Gates Funding For Tuberculosis Drug Research (si apre in una nuova scheda)

  Simply Wall Street · 1 ott 2026

• GSK continues to stock up on Wave's RNA drugs with liver-focused program (si apre in una nuova scheda)

  Fierce Biotech · 30 set 2026

• Does GSK (LSE:GSK) Have Fresh Momentum As London Pharma Gets A Lift From Cancer Dealmaking With FTSE 100 In Focus? (si apre in una nuova scheda)

  Kalkine Media · 30 set 2026

• GSK selects Wave Life Sciences hepatology candidate By Investing.com (si apre in una nuova scheda)

  Investing.com UK · 30 set 2026

• Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development (si apre in una nuova scheda)

  Yahoo Finance · 30 set 2026

• GSK (LSE:GSK) The Latest Update Raises A Bigger Question (si apre in una nuova scheda)

  30 set 2026

• Hatteras Venture Partners Names Sir Andrew Witty as Chairman and Ned Sharpless, M.D., as Managing Director of Hatteras Discovery Innovation, Expanding Proven Investment Strategies (si apre in una nuova scheda)

  30 set 2026

• Can GSK shares outperform FTSE 100 index over the long run? (si apre in una nuova scheda)

  Interactive Investor · 30 set 2026

• Spotlight On: GSK's HBV hopeful tops FDA's October agenda (si apre in una nuova scheda)

  FirstWord Pharma · 29 set 2026

• Re-entering the Dragon: GSK returns to China after 12 years in blood cancer drug push (si apre in una nuova scheda)

  This is Money · 29 set 2026

• GSK retains ‘buy’ rating at Jefferies as B7H3 cancer programme seen as underappreciated (si apre in una nuova scheda)

  Proactive financial news · 29 set 2026

• GSK vs. SNY: Which Europe-Based Pharma Stock Has More Potential? (si apre in una nuova scheda)

  29 set 2026